Inagami T, Hirose S, Murakami K, Matoba T
J Biol Chem. 1977 Nov 10;252(21):7733-7.
Renin (EC 3.4.99.19) has been observed to exist in a high molecular weight (Mr greater than 50,000) and a low molecular weight from (Mr approximately 42,000) in various tissues. Little is known concerning the origin and function of the high molecular weight form of renin and its relationship to low molecular weight renin. We have found that the high molecular weight form of renin in the kidney was converted to the low molecular weight form during the extraction process. The conversion is apparenly catalyzed by an agent(s) which requires free sulfhydryl groups since blockers of sulfhydryl groups completely suppress the conversion. This conversion could not be prevented by various specific inhibitors of serine proteases nor by the metal chelator EDTA. By the use of Na-tetrathionate it was possible to preserve the renin activity of hog kidney exclusively in the high molecular weight form. Similarly, using N-ethylmaleimide it was shown that a similar high molecular weight form of renin is the exclusive form present in rat kidney. These results suggest that the high molecular weight form of renin is the native form stored in the kidney and that it is converted by an enzyme or agent requiring sulfhydryl groups to the circulating (low molecular weight) form when it is secreted into blood. Renin activity was increased to approximately 155% of the original level upon conversion.
在各种组织中,已观察到肾素(EC 3.4.99.19)以高分子量(Mr大于50,000)和低分子量形式(Mr约为42,000)存在。关于高分子量形式肾素的起源、功能及其与低分子量肾素的关系,人们了解甚少。我们发现,肾脏中高分子量形式的肾素在提取过程中会转化为低分子量形式。这种转化显然是由一种需要游离巯基的因子催化的,因为巯基阻断剂会完全抑制这种转化。丝氨酸蛋白酶的各种特异性抑制剂以及金属螯合剂乙二胺四乙酸(EDTA)都无法阻止这种转化。通过使用连四硫酸钠,可以仅以高分子量形式保留猪肾的肾素活性。同样,使用N - 乙基马来酰亚胺表明,大鼠肾脏中存在的也是类似的高分子量形式的肾素。这些结果表明,高分子量形式的肾素是储存在肾脏中的天然形式,当它分泌到血液中时,会被一种需要巯基的酶或因子转化为循环(低分子量)形式。转化后肾素活性增加到原来水平的约155%。